Added to YB: 2025-12-17
Pitch date: 2025-12-13
CYRX [bullish]
Cryoport, Inc.
-2.54%
current return
Author Info
The Financial Pen is a finance industry veteran hunting mispriced quality. They investigate misunderstood opportunities, spotlight overlooked bets, and deploy capital across U.S. and pan-Asian markets. Sign up for the newsletter.
Company Info
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$506.9M
Pitch Price
$9.46
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.85
P/E
-4.16
EV/Sales
2.23
Sector
Life Sciences Tools and Services
Category
value
Cryoport (CYRX): Buying the Toll Road to the Future of Medicine
CYRX: Cryogenic logistics for cell/gene therapies with 36% YOY commercial CGT growth Q3. 745 trials supported, 19 commercial therapies vs 9 two years ago. Near EBITDA breakeven, 48% gross margins, $236M net cash. EV ~1.4x sales vs peers at 11x. Risks: CGT pipeline delays, operational failures, point-of-care disruption.
Read full article (24 min)